FIBROGEN
Live / Registered — Registered and renewed (as of 04 Jun 2021)
What this means for you
Registered since 07 Feb 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Feb 2022).
Record
- Serial number
- 77728286
- Registration number
- 4096522
- Mark type
- Stylized text
- Filed
- 04 May 2009
- Published for opposition
- 08 Sept 2009
- Registered
- 07 Feb 2012
- Next maintenance due
- 07 Feb 2022
- Attorney of record
- Harold Milstein
Goods and services
- Class 005 — Pharmaceuticals: Anti-connective tissue growth factor antibodies for clinical or pharmaceutical use
Owner
- FibroGen, Inc., San Francisco, CA, US
- FibroGen, Inc., San Francisco, CA, US
- FibroGen, Inc., San Francisco, CA, US
Prior registrations
Prosecution history
- 07 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Oct 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Oct 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Oct 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Oct 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Apr 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Apr 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Jun 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 04 Jun 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 04 Jun 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 04 Jun 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Mar 2021 — TEAS SECTION 8 & 9 RECEIVED
- 07 Feb 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 14 Apr 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED